May 1, 2023 – Johnson & Johnson Innovation LLC, in collaboration with the Population Health Research team at Janssen Scientific Affairs, LLC, named LUNGevity Foundation and Miami Cancer Institute, part of Baptist Health South Florida, as awardees in the Advancing Health Equity QuickFire Challenge. As an awardee, Miami Cancer Institute, in collaboration with LUNGevity Foundation, will receive grant funding to develop and implement a geographically tailored and patient-centric lung cancer screening education program for the Latinx community.
“It brings us great joy to be able to offer our patients lung cancer screening. As our Institute serves the patients in South Florida, we look forward to bringing quality care to even more patients, those coming from abroad and from low-income communities in South Florida,” shared Manmeet S. Ahluwalia, M.D., M.B.A, FASCO, deputy director, chief scientific officer, and chief of medical oncology at Miami Cancer Institute, and Fernandez Family Foundation Endowed Chair in Cancer Research. “It’s a personal mission of mine to address health disparities, specifically in cancer. We feel extremely grateful to bring this program to Miami Cancer Institute and thank LUNGevity for choosing us as a co-collaborator.”
In 2022, Janssen’s Population Health Research team and Johnson & Johnson Innovation launched the Advancing Health Equity QuickFire Challenge to move from detection to the design and implementation of interventions to reduce healthcare inequities deeply rooted in our society. The grant funding comes from a total pool of $400,000 for organizations, such as LUNGevity Foundation, to launch programs and campaigns to fill the health equity gaps on topics of importance to historically marginalized communities. In addition to the International Myeloma Foundation and Memorial Sloan Kettering Cancer Center with Prostate Cancer Health Education Network (PHEN), LUNGevity Foundation in collaboration with Miami Cancer Institute have been awarded this prestigious award.
For more information on the Advancing Health Equity QuickFire Challenge, visit here. To learn more about the LUNGevity Foundation and Miami Cancer Institute lung cancer screening education program, visit here.
About Miami Cancer Institute
Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services delivered with unparalleled compassion. No other cancer program in the region has the combination of cancer-fighting expertise and advanced technology—including the first proton therapy center in South Florida, Latin America and the Caribbean, and one of the only radiation oncology programs in the world with each of the newest radiation therapies in one place—to diagnose and deliver precise cancer treatments that achieve the best outcomes and improve the lives of cancer patients. The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected as Florida’s only member of the Memorial Sloan Kettering Cancer (MSK) Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at MSK. For more information, please visit https://cancer.baptisthealth.net/miami-cancer-institute.
Miami Cancer Institute is part of Baptist Health Cancer Care, the largest cancer program in South Florida, with locations from the Florida Keys to the Palm Beaches.
